AstraZeneca PLC
corporate_fare Company Profile
AstraZeneca PLC (NYSE:AZN) is a publicly traded company in the Life Sciences sector. Wiseek monitors AZN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- AstraZeneca Delivers Strong Q1 Growth, Reaffirms FY26 Guidance, and Highlights Key Pipeline Wins & $1.2B Collaboration
- AstraZeneca's Breztri Approved by US FDA for Asthma, First Triple Therapy for Patients 12+
- AstraZeneca's Saphnelo Approved for US Self-Administration in Systemic Lupus Erythematosus
- AstraZeneca's Ultomiris Achieves Primary Endpoint in Phase III IgAN Trial, Paving Way for Accelerated Approval
- AstraZeneca's Tozorakimab Achieves Third Positive Phase III Trial in COPD
Financial Snapshot
Insider Transactions
AZN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.